BANK OF MONTREAL /CAN/ - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 78 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$138,000
+25.5%
23,6140.0%0.00%
Q4 2017$110,000
+15.8%
23,614
+37.0%
0.00%
Q3 2017$95,000
-12.8%
17,238
-9.1%
0.00%
Q2 2017$109,000
+73.0%
18,961
+110.7%
0.00%
Q4 2014$63,000
+14.5%
9,0000.0%0.00%
Q3 2014$55,000
-33.7%
9,000
-1.6%
0.00%
Q2 2014$83,000
+45.6%
9,150
+30.7%
0.00%
Q1 2014$57,0007,0000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders